The ABC of glycosylation

Nature Reviews Cancer

Volumn 10, Issue 7, 2010, Pages 523-

  Perego, Paola ^a   Gatti, Laura ^a   Beretta, Giovanni L ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CISPLATIN; GLYCOPROTEIN P; GLYCOSYLTRANSFERASE;

CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; ENDOPLASMIC RETICULUM; GENE MUTATION; GLYCOSYLATION; HUMAN; LETTER; LYSOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING;

ATP-BINDING CASSETTE TRANSPORTERS; GLYCOSYLATION; HUMANS; NEOPLASMS;

EID: 77954034064     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2789-c1     Document Type: Letter

References (25)

1. Fletcher, J. I., Haber, M., Henderson, M. J. & Norris, M. D. ABC transporters in cancer: more than just drug efflux pumps. Nature Rev. Cancer 10, 147-156 (2010).
2. Gillet, J.-P., Efferth, T. & Remacle, J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochem. Biophys. Acta 1775, 237-262 (2007).
3. Gatti, L., Beretta, G. L., Cossa, G., Zunino, F. & Perego, P. ABC transporters as potential targets for modulation of drug resistance. Mini Rev. Med. Chem. 9, 1102-1112 (2009).
4. Faggad, A. et al. Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology 54, 657-666 (2009).
5. Leonard, G. D., Fojo, T. & Bates, S. E. The role of ABC transporters in clinical practice. Oncologist 8, 411-424 (2003).
6. Richert, N. D., Aldwin, L., Nitecki, D., Gottesman, M. M. & Pastan, I. Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells. Biochemistry 27, 7607-7613 (1988).
7. Liang, X. J., Shen, D. W., Garfield, S. & Gottesman, M. M. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Cancer Res. 63, 5909-5916 (2003).
8. Wakabayashi-Nakao, K., Tamura, A., Furukawa, T., Nakagawa, H. & Ishikawa, T. Quality control of human ABCG2 protein in the endoplasmic reticulum: ubiquitination and proteasomal degradation. Adv. Drug Deliv. Rev. 61, 66-71 (2009).
9. Nakagawa, H. et al. Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2. FEBS J. 6, 7237-7252 (2009).
10. Furukawa, T. et al. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Pharm. Res. 26, 469-479 (2009).
11. Nakagawa, H. et al. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. Biochem. J. 4 11, 623-631 (2008).
12. Beretta, G. L. et al. Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochem. Pharmacol. 79, 1108-1117 (2010).
13. Sieczkowski, E., Lehner, C., Ambros, P. F. & Hohenegger, M. Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells. Int. J. Cancer. 126, 2025-2035 (2010).
14. Risbridger, G. P., Davis, I. D., Birrell, S. N., Tilley, W. D. Breast and prostate cancer: more similar than different. Nature R e v. Cancer 10, 205-212 (2010).
15. Tryggvadottir, L. et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J. Natl Cancer Inst. 99, 929-935 (2007).
16. Easton, D. F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093 (2007).
17. Eeles, R. A. et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nature Genet. 40, 316-321 (2008).
18. Gudmundsson, J. et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nature Genet. 40, 281-283 (2008). (Pubitemid 351311771)
19. Thomas, G. et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nature Genet. 40, 310-315 (2008).
20. Hemminki, K., Li, X., Plna, K., Granström C & Vaittinen, P. The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol. 40, 772-777 (2001). (Pubitemid 33081988)
21. Hemminki, K. and Chen, B. Familial association of prostate cancer with other cancers in the Swedish-Family-Cancer Database. Prostate 65,188-194 (2005).
22. Hemminki, K., Vaittinen, P., Dong, C. & Easton, D. Sibling risks in cancer: clues to recessive or X-linked genes? B r. J. Cancer 84, 388-391 (2001).
23. Hemminki, K., Sundquist, J. & Lorenzo Bermejo, J. Familial risks for cancer as the basis for evidence-based clinical referral and counseling. The Oncologist 13, 239-247 (2008).
24. Lorenzo Bermejo, J. & Hemminki, K. A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations. Ann. Oncol.16, 322-329 (2005).
25. Chen, S. et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J. Clin. Oncol. 24, 863-871 (2006).